MATRIX LABORATORIES

Highlights :


1. Dividend Paying, High Operating Profits

2. Many recent overseas acquisitions

3. Entering into new high profit and niche areas of pharma with backward integration with inventors and research companies, also entering into forward integration for higher sales in Europe.

4. All production facilities are already approved by the USFDA and leading International and European Pharma Regulatory Authorities.

5. Filed more than 80 DMF's in the US and Europe and have also filed more than 35 innovative patents.

6. Matrix successfully developed non infringing process for Citalopram and so far generated revenues of US 3 Million with average gross margins of more than 75%.

7. Best operating margins in the industry. Matrix has more than 200 scientists working on Research and Developments of New Molecules and Products.

8. Contract Manufacturing for large foreign Pharma Majors.

9. Matrix Labs has sales and marketing offices in many countries. Prism Cement

10. Stock having holding by Temasek (Singapore Government’s Investment wing)